サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1762319

性感染症分子診断市場、規模、シェア、動向、産業分析レポート：製品別、用途別、技術別、地域別、2025年～2034年の市場予測

Molecular Diagnostics For Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 123 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
性感染症分子診断市場、規模、シェア、動向、産業分析レポート：製品別、用途別、技術別、地域別、2025年～2034年の市場予測
出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 123 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、性感染症分子診断の世界市場規模は2034年までに78億5,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

性感染症（STDs）分子診断には、これらの感染症の原因となる微生物のDNAやRNAなどの遺伝物質を特定する高度な実験技術が含まれます。抗体や培養液を調べるような旧来の方法とは異なり、分子検査では病原体そのものを直接特定します。これにより、高精度で高感度な検出が可能になり、感染の初期段階や症状がまだ現れていない段階でも診断が可能になることが多いです。

性感染症分子診断市場は、世界の性病罹患率の上昇により大きな成長を遂げており、公衆衛生の課題を管理するためにより効果的で迅速な診断ソリューションが必要とされています。さらに、複数の病原体を同時に検出できるマルチプレックスアッセイの開発など、分子検査における継続的な技術進歩により、検査効率とアクセシビリティが向上しています。早期かつ正確なSTD診断の重要性に対するヘルスケア専門家や一般市民の意識の高まりも、こうした高度な診断法の採用拡大に寄与しています。

性感染症分子診断市場レポートハイライト

製品別では、試薬とキットを含む消耗品分野が、あらゆる分子性病検査において重要な役割を果たすため、最大のシェアを占めています。

用途別では、CT/NG検査分野が2024年に支配的でした。

技術面では、集中型ラボの確立されたインフラに支えられ、ラボ検査セグメントが2024年に最大のシェアを占めました。

地域別では、北米が2024年の性感染症用分子診断薬市場の売上高シェアを独占しました。アジア太平洋地域は予測期間中に最も急成長すると予測されています。

同市場の主要企業には、Abbott Laboratories、F. Hoffmann-La Roche AG（Roche Diagnostics）、bioMerieux SA、QIAGEN N.V.、Hologic Inc.、Becton, Dickinson and Company（BD）、Siemens Healthineers AG、DiaSorin S.p.A.、Thermo Fisher Scientific Inc.、QuidelOrtho Corporation、Seegene Inc.などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 性感染症分子診断における世界の市場分析

  • 市場スナップショット
  • 性感染症分子診断市場力学
    • 促進要因と機会
      • 性感染症の発生率の増加
      • 診断ツールにおける技術的進歩
    • 抑制要因と課題
      • 診断検査と機器の高コスト
  • PESTEL分析
  • 性感染症分子診断市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 性感染症分子診断市場：製品別

  • 主な調査結果
  • イントロダクション
  • 機器とサービス
  • 消耗品
  • ソフトウェア

第6章 性感染症分子診断市場：用途別

  • 主な調査結果
  • イントロダクション
  • CT/NG検査
  • 梅毒検査
  • 淋病検査
  • HSV検査
  • HPV検査
  • HIV検査
  • トリコモナス
  • ウレアプラズマ+ マイコプラズマ
  • その他

第7章 性感染症分子診断の世界市場：技術別

  • 主な調査結果
  • イントロダクション
  • 臨床検査
  • PoCテスト

第8章 性感染症分子診断市場：地域別

  • 主な調査結果
  • イントロダクション
    • 性感染症分子診断市場評価：地域別、2020～2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：用途別、2020～2034年
    • 北米：技術別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 欧州：技術別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：用途別、2020～2034年
    • アジア太平洋地域：技術別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • 中東・アフリカ：技術別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • ラテンアメリカ：技術別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • bioMerieux SA
  • DiaSorin S.p. A.
  • F. Hoffmann-La Roche AG（Roche Diagnostics）
  • Hologic Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
図表

List of Tables:

  • Table 1 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 7 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 10 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 22 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 43 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 46 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 58 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 91 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2024 & 2034 (USD Billion)
目次
Product Code: PM5807

The global molecular diagnostics for sexually transmitted diseases market size is expected to reach USD 7.85 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics for Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular diagnostics for sexually transmitted diseases (STDs) involves advanced laboratory techniques that pinpoint the genetic material, such as DNA or RNA, of the microorganisms causing these infections. Unlike older methods that might look for antibodies or grown cultures, molecular tests directly identify the pathogen itself. This allows for highly accurate and sensitive detection, often enabling diagnosis even in the early stages of an infection or when symptoms are not yet present, which is crucial for timely treatment and preventing further spread.

The market for molecular diagnostics for STDs is experiencing significant growth due to the rising global incidence of STDs, which necessitates more effective and rapid diagnostic solutions to manage public health challenges. Additionally, ongoing technological advancements in molecular testing, including the development of multiplex assays that can detect multiple pathogens simultaneously, are enhancing testing efficiency and accessibility. The increasing awareness among healthcare professionals and the general public about the importance of early and accurate STD diagnosis also contributes to the expanding adoption of these advanced diagnostic methods.

Molecular Diagnostics for Sexually Transmitted Diseases Market Report Highlights:

By product, the consumables segment, encompassing reagents and kits, holds the largest share due to its essential role in every molecular STD test.

Based on application, the CT/NG testing segment dominated in 2024 as these are among the most prevalent STDs worldwide.

In terms of technology, the laboratory testing segment held the largest share in 2024, supported by the established infrastructure of centralized labs.

By region, North America dominated the molecular diagnostics for sexually transmitted diseases market revenue share in 2024. Asia Pacific is projected to witness the fastest growth during the forecast period.

A few key players in the market include Abbott Laboratories; F. Hoffmann-La Roche AG (Roche Diagnostics); bioMerieux SA; QIAGEN N.V.; Hologic Inc.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; DiaSorin S.p.A.; Thermo Fisher Scientific Inc.; QuidelOrtho Corporation; and Seegene Inc.

Polaris Market Research has segmented the molecular diagnostics for sexually transmitted diseases market report on the basis of product, application, technology, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Instruments & Services

Consumables

Software

By Application Outlook (Revenue - USD Billion, 2020-2034)

CT/NG Testing

Syphilis Testing

Gonorrhea Testing

HSV Testing

HPV Testing

HIV Testing

Trichomonas

Ureaplasma + Mycoplasma

Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Laboratory Testing

Commercial/Private Labs

Public Health Labs

PoC testing

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Insights

  • 4.1. Molecular Diagnostics For Sexually Transmitted Diseases Market - Market Snapshot
  • 4.2. Molecular Diagnostics For Sexually Transmitted Diseases Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Incidence of Sexually Transmitted Diseases
      • 4.2.1.2. Technological Advancements in Diagnostic Tools
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Diagnostic Tests and Equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Instruments & Services
    • 5.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Instruments & Services, by Region, 2020-2034 (USD Billion)
  • 5.4. Consumables
    • 5.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Consumables, by Region, 2020-2034 (USD Billion)
  • 5.5. Software
    • 5.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  • 6.3. CT/NG testing
    • 6.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by CT/NG testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Syphilis testing
    • 6.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Syphilis testing, by Region, 2020-2034 (USD Billion)
  • 6.5. Gonorrhea testing
    • 6.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Gonorrhea testing, by Region, 2020-2034 (USD Billion)
  • 6.6. HSV testing
    • 6.6.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HSV testing, by Region, 2020-2034 (USD Billion)
  • 6.7. HPV testing
    • 6.7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HPV testing, by Region, 2020-2034 (USD Billion)
  • 6.8. HIV testing
    • 6.8.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HIV testing, by Region, 2020-2034 (USD Billion)
  • 6.9. Trichomonas
    • 6.9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Trichomonas, by Region, 2020-2034 (USD Billion)
  • 6.10. Ureaplasma + Mycoplasma
    • 6.10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Ureaplasma + Mycoplasma, by Region, 2020-2034 (USD Billion)
  • 6.11. Others
    • 6.11.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Laboratory Testing
    • 7.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Laboratory Testing, by Region, 2020-2034 (USD Billion)
    • 7.3.2. Commercial/Private Labs
    • 7.3.3. Public Health Labs
  • 7.4. PoC testing
    • 7.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by PoC testing, by Region, 2020-2034 (USD Billion)

8. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Molecular Diagnostics For Sexually Transmitted Diseases Market - North America
    • 8.3.1. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - U.S.
      • 8.3.4.1. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Canada
      • 8.3.5.1. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Europe
    • 8.4.1. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - UK
      • 8.4.4.1. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - France
      • 8.4.5.1. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Germany
      • 8.4.6.1. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Italy
      • 8.4.7.1. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Spain
      • 8.4.8.1. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - Netherlands
      • 8.4.9.1. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Russia
      • 8.4.10.1. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Asia Pacific
    • 8.5.1. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - China
      • 8.5.4.1. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - India
      • 8.5.5.1. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Malaysia
      • 8.5.6.1. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Japan
      • 8.5.7.1. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Indonesia
      • 8.5.8.1. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Korea
      • 8.5.9.1. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Australia
      • 8.5.10.1. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - UAE
      • 8.6.5.1. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Israel
      • 8.6.6.1. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Africa
      • 8.6.7.1. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
  • 8.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Latin America
    • 8.7.1. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Mexico
      • 8.7.4.1. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Brazil
      • 8.7.5.1. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Argentina
      • 8.7.6.1. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. DiaSorin S.p. A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche AG (Roche Diagnostics)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. QIAGEN N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. QuidelOrtho Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Seegene Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development